Vanderbilt University: Clinical Trials

81 trials sponsored by Vanderbilt University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

58 completed, 12 terminated, 8 withdrawn, 2 active not recruiting. 81 Phase 2, 12 Phase 3, 9 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 281Completed 58, Terminated 12, Withdrawn 8, Active not recruiting 2, Enrolling by invitation 1
Phase 312Completed 9, Withdrawn 2, Terminated 1
Phase 19Completed 6, Terminated 2, Withdrawn 1

Follow Vanderbilt University: new trials by email

Trials (filtered) newest first · largest first

All 81 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Maximizing Outcomes for Preschoolers With Developmental Language Disorders
the Enhanced Milieu Teaching-Sentence Focus - Developmental Language Disorder
Phase 2CompletedNorthwestern University1082019-04-042026-08-19
Nitroglycerin vs. Furosemide Using Lung Ultrasound Pilot Trial
Nitrates, Loop Diuretics - Heart Failure, Heart Failure Acute
Phase 2TerminatedIndiana University522017-12-142024-08-20
Pulmonary Hypertension and Anastrozole Trial
Anastrozole, Placebo Oral Tablet - Pulmonary Arterial Hypertension
Phase 2CompletedUniversity of Pennsylvania842017-12-072024-05-01
Ruxolitinib + Allogeneic Stem Cell Transplantation in AML
Ruxolitinib - Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission
Phase 2Active not recruitingMassachusetts General Hospital642017-11-032026-03-27
A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
Nivolumab, Ipilimumab - Acral Lentiginous Melanoma, Mucosal Melanoma
Phase 2TerminatedGeorgetown University142017-07-262024-04-04
B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial
LUS-guided strategy-of-care, Usual Care, Intravenous Loop Diuretic - Heart Failure, Heart Failure Acute
Phase 2CompletedIndiana University1302017-07-102024-06-04
Trial of Brigatinib After Treatment With Next-Generation ALK Inhibitors
brigatinib - Non-Small Cell Lung Cancer
Phase 2TerminatedCriterium, Inc.322017-03-092023-01-26
Memory Improvement Through Nicotine Dosing (MIND) Study
Nicotine Transdermal Patch, Placebo Patch - Mild Cognitive Impairment
Phase 2CompletedUniversity of Southern California3482017-02-222026-09-17
Interventions for Reading Disabilities in NF1
Lovastatin, reading tutoring intervention, Placebo Oral Tablet - Neurofibromatosis Type 1, Learning Disability
Phase 2Active not recruitingVanderbilt University1202016-11-012026-07-01
New Formulations of Propafenone to Treat Atrial Fibrillation
(R)-propafenone, (S)-Propafenone, Placebo - Atrial Fibrillation
Phase 1 / Phase 2TerminatedVanderbilt University1932016-10-012022-06-03
Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease
Azithromycin, Placebo - Sickle Cell Disease
Phase 1 / Phase 2WithdrawnVanderbilt University2016-09-012018-10-02
A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia
Nintedanib and AML induction - Relapsed/Refractory Acute Myeloid Leukemia
Phase 2CompletedYale University252016-07-212022-04-08
Risk of Oxygen During Cardiac Surgery Trial
Oxygen - normoxia, Oxygen - hyperoxia - Cardiac Surgery
Phase 2 / Phase 3CompletedVanderbilt University2132016-04-052024-02-01
Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer
Carboplatin, Etoposide, MPDL3280A - Small Cell Lung Cancer ( SCLC )
Phase 1 / Phase 2TerminatedGiuseppe Giaccone12016-03-012018-07-02
Trial of Oral Glutamine on Mitochondrial Function in CKD
First Intervention (14 days), Washout (3 weeks), Second Intervention (14 days) - Cardiovascular Disease, Sarcopenia
Phase 2CompletedUniversity of Washington112016-02-252022-07-14
Contrast-enhanced Ultrasound of the Kidney
Perflutren lipid microsphere - Chronic Kidney Disease, Cystic Kidney Disease
Phase 2CompletedUniversity of North Carolina, Chapel Hill632016-02-012019-09-26
The SCCS Polypill Pilot Trial
Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide) - Hypertension, Hyperlipidemia
Phase 2CompletedVanderbilt University3032015-12-012021-05-14
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
CliniMacs TCR alpha-beta-Biotin system - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2Enrolling by invitationMichael Pulsipher502015-10-012025-05-04
Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety Study
Spironolactone, Placebo - Acute Heart Failure
Phase 2WithdrawnIndiana University2015-05-012017-04-21
Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
Spironolactone - End-Stage Renal Disease
Phase 2CompletedUniversity of Pennsylvania1292014-11-012019-07-23

Showing 20 of 81. Sign in to see all of them.

Conditions studied

Kidney Failure, Chronic (12)  ·  Renal Insufficiency, Chronic (6)  ·  Cognitive Dysfunction (3)  ·  Delirium (3)  ·  Inflammation (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Acute Kidney Injury (2)  ·  Atrial Fibrillation (2)  ·  Autonomic Nervous System Diseases (2)  ·  Breast Neoplasms (2)  ·  Cardiovascular Diseases (2)  ·  Depression (2)  ·  Depressive Disorder, Major (2)  ·  HIV Infections (2)  ·  Heart Defects, Congenital (2)

Interventions

Dietary Supplements (4)  ·  Exercise (4)  ·  Spironolactone (4)  ·  Azithromycin (3)  ·  Citrulline (3)  ·  Dexmedetomidine (2)  ·  Diet (2)  ·  Ethambutol (2)  ·  Gamma Rays (2)  ·  Levofloxacin (2)  ·  Raltegravir Potassium (2)  ·  Ramipril (2)  ·  Rifampin (2)  ·  Saline Solution (2)  ·  Thioctic Acid (2)

Countries

United States (78)  ·  Canada (1)

Top investigators

Alp Ikizler, MD (16)  ·  Jonathan Himmelfarb, MD (3)  ·  E Wesley Ely, MD, MPH (2)  ·  Peter S Pang, MD (2)  ·  Albert C. Lockhart, M.D. (1)  ·  Alfredo J Gamboa, MD (1)  ·  Allen Pantuck, MD (1)  ·  Andrew Winokur, M.D. (1)  ·  Ann Kaiser, PhD (1)  ·  Ben Shoemaker, MD (1)  ·  Beth Malow, M.D., M.S. (1)  ·  Bettie M Steinberg, PhD (1)  ·  Bjorn Knollmann, MD/PhD (1)  ·  Brian W. Christman, MD (1)  ·  Christian Lattermann, MD (1)

Results publications

PMID 32390133, PMID 11739090, PMID 14678952, PMID 15213282, PMID 17227907, PMID 17662768, PMID 18073360, PMID 18513353, PMID 18711110, PMID 18824641, PMID 20095068, PMID 20233428, PMID 20599398, PMID 21242788, PMID 22158433, PMID 22626819, PMID 22823027, PMID 22824930, PMID 22869834, PMID 23013802, PMID 23290327, PMID 23361105, PMID 23863960, PMID 24349334, PMID 25232828, PMID 25424850, PMID 25468655, PMID 25659187, PMID 26494370, PMID 27089159, PMID 27279368, PMID 28146402, PMID 28651648, PMID 29137655, PMID 29363356, PMID 29746485, PMID 30033738, PMID 30448355, PMID 31532959, PMID 31810978, PMID 33039599, PMID 33586138, PMID 34246609, PMID 34291724, PMID 35018639, PMID 35435017, PMID 35776909, PMID 35963181, PMID 36166682, PMID 37156670

NIH funding

R01DK045604 (3), K23DK099442 (1), P01HL056693 (1), R01AG047992 (1), R01CA160938 (1), R01GM112871 (1), R01HD089474 (1), R01HL065193 (1), R01HL073317 (1), R01HL077389 (1), R01HL117074 (1), R01HL124935 (1), R01HL134905 (1), R01MH077596 (1), R01NS042698 (1)